Evidence map›Paper›PMID 42518698›Full record

ArticleMaterials today. Bio2026

Synergistic eradication of NDM-1

Zhaoyou Chu, Shu Fang, Wanyue Fu, Jun Liang, Yayun Wu, Ling Xu, Hanqing Zhang, Jiyang Wang, Haisheng Qian, Min Shao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhaoyou ChuDepartment of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Shu FangSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230012, China.
Wanyue FuSchool of Pharmacy, Anhui Medical University, Hefei, 230032, China.
Jun LiangSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230012, China.
Yayun WuDepartment of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Ling XuSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230012, China.
Hanqing ZhangSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230012, China.
Jiyang WangDepartment of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.
Haisheng QianSchool of Biomedical Engineering, Anhui Medical University, Hefei, 230012, China.
Min ShaoDepartment of Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New Delhi metallo-β-lactamase (NDM)-producing drug-resistant bacteria often form stubborn biofilms and cause severe pneumonia, resulting in conventional antibiotic failure. In this study, we developed gelatin-genipin microspheres co-loaded with EDTA and meropenem (GEM) for targeted treatment of NDM pneumonia. EDTA exerted dual functions: it chelated Zn

Indexed as

BiofilmMicrospheresNDM-Producing bacteriaPneumonia

Identifiers

PMID42518698
PMCPMC13383260

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.